These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12543646)

  • 1. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.
    Van Voorhis WC; Barrett LK; Eastman RT; Alfonso R; Dupuis K
    Antimicrob Agents Chemother; 2003 Feb; 47(2):475-9. PubMed ID: 12543646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Salata J; Mendez J; Reddy H; Goodrich R
    Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.
    Eastman RT; Barrett LK; Dupuis K; Buckner FS; Van Voorhis WC
    Transfusion; 2005 Sep; 45(9):1459-63. PubMed ID: 16131378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of T. cruzi infected human platelet concentrates with aminomethyltrimethyl psoralen (AMT) and ultraviolet A (UV-A) light: preliminary results.
    Moraes-Souza H; Bordin JO; Bardossy L; Blajchman MA
    Rev Soc Bras Med Trop; 1996; 29(1):47-9. PubMed ID: 8851215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.
    Lanteri MC; Santa-Maria F; Laughhunn A; Girard YA; Picard-Maureau M; Payrat JM; Irsch J; Stassinopoulos A; Bringmann P
    Transfusion; 2020 Jun; 60(6):1319-1331. PubMed ID: 32333396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.
    Castro E; Gironés N; Bueno JL; Carrión J; Lin L; Fresno M
    Transfusion; 2007 Mar; 47(3):434-41. PubMed ID: 17319823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
    Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
    Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light.
    Lin L; Hanson CV; Alter HJ; Jauvin V; Bernard KA; Murthy KK; Metzel P; Corash L
    Transfusion; 2005 Apr; 45(4):580-90. PubMed ID: 15819680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light.
    Hindawi SI; El-Kafrawy SA; Hassan AM; Badawi MA; Bayoumi MM; Almalki AA; Zowawi HM; Tolah AM; Alandijany TA; Abunada Q; Picard-Maureau M; Damanhouri GA; Azhar EI
    Transfus Clin Biol; 2022 Feb; 29(1):31-36. PubMed ID: 34411748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light.
    Gottlieb P; Margolis-Nunno H; Robinson R; Shen LG; Chimezie E; Horowitz B; Ben-Hur E
    Photochem Photobiol; 1996 May; 63(5):562-5. PubMed ID: 8628745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function.
    Singh Y; Sawyer LS; Pinkoski LS; Dupuis KW; Hsu JC; Lin L; Corash L
    Transfusion; 2006 Jul; 46(7):1168-77. PubMed ID: 16836564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
    Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
    Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates.
    Nebie O; Devos D; Vingtdeux V; Barro L; Devedjian JC; Jonneaux A; Chou ML; Bordet R; Buée L; Knutson F; Blum D; Burnouf T
    J Biomed Sci; 2019 Oct; 26(1):89. PubMed ID: 31666073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
    Azhar EI; Hindawi SI; El-Kafrawy SA; Hassan AM; Tolah AM; Alandijany TA; Bajrai LH; Damanhouri GA
    Vox Sang; 2021 Jul; 116(6):673-681. PubMed ID: 33277935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.
    Brouard N; Pissenem-Rudwill F; Mouriaux C; Haas D; Galvanin A; Kientz D; Mangin PH; Isola H; Hechler B
    Transfusion; 2023 Oct; 63(10):1937-1950. PubMed ID: 37615493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors.
    Cancino-Faure B; Fisa R; Riera C; Bula I; Girona-Llobera E; Jimenez-Marco T
    Transfusion; 2015 Jun; 55(6):1249-55. PubMed ID: 25683267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
    Kaiser-Guignard J; Canellini G; Lion N; Abonnenc M; Osselaer JC; Tissot JD
    Blood Rev; 2014 Nov; 28(6):235-41. PubMed ID: 25192602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.